Total (n = 1,923) | % | P (n = 85) | % | LP (n = 62) | % | non-P (n = 1,776) | % | P (P vs. non-P) | P (LP vs. non-P) | |
---|---|---|---|---|---|---|---|---|---|---|
Stage | 0.13 | 0.00032 | ||||||||
I | 183 | 0.095 | 2 | 0.024 | 1 | 0.016 | 180 | 0.101 | ||
II | 833 | 0.433 | 39 | 0.459 | 37 | 0.597 | 757 | 0.426 | ||
III | 527 | 0.274 | 25 | 0.294 | 6 | 0.097 | 496 | 0.279 | ||
IV | 380 | 0.198 | 19 | 0.224 | 18 | 0.29 | 343 | 0.193 | ||
Age | 0.001 | 0 | ||||||||
<40 | 182 | 0.095 | 16 | 0.188 | 4 | 0.065 | 162 | 0.091 | ||
40–49 | 332 | 0.173 | 21 | 0.247 | 25 | 0.403 | 286 | 0.161 | ||
50–59 | 511 | 0.266 | 18 | 0.212 | 14 | 0.226 | 479 | 0.270 | ||
≥60 | 810 | 0.421 | 25 | 0.294 | 15 | 0.242 | 770 | 0.434 | ||
NA | 88 | 0.046 | 5 | 0.059 | 4 | 0.065 | 79 | 0.044 | ||
Gender | 0.458 | 0.288 | ||||||||
Male | 1130 | 0.588 | 52 | 0.612 | 33 | 0.532 | 1045 | 0.588 | ||
Female | 728 | 0.379 | 28 | 0.329 | 28 | 0.452 | 672 | 0.378 | ||
NA | 65 | 0.034 | 5 | 0.059 | 1 | 0.016 | 59 | 0.033 | ||
Family history | 0.014 | 0.026 | ||||||||
Yes | 111 | 0.058 | 8 | 0.094 | 7 | 0.113 | 96 | 0.054 | ||
No | 734 | 0.382 | 21 | 0.247 | 19 | 0.306 | 694 | 0.391 | ||
NA | 1078 | 0.561 | 56 | 0.659 | 36 | 0.581 | 986 | 0.555 | ||
MSI status | 0 | 0 | ||||||||
MSI-H | 113 | 0.059 | 25 | 0.294 | 18 | 0.290 | 68 | 0.038 | ||
MSI-L | 21 | 0.011 | 2 | 0.024 | 2 | 0.032 | 17 | 0.010 | ||
MSS | 1577 | 0.820 | 47 | 0.553 | 38 | 0.613 | 1492 | 0.840 | ||
NA | 214 | 0.111 | 11 | 0.129 | 4 | 0.065 | 199 | 0.112 | ||
MMR status | 0 | 0 | ||||||||
dMMR | 82 | 0.043 | 19 | 0.224 | 15 | 0.242 | 48 | 0.027 | ||
pMMR | 750 | 0.390 | 27 | 0.318 | 11 | 0.177 | 712 | 0.401 | ||
NA | 1091 | 0.567 | 39 | 0.459 | 36 | 0.581 | 1016 | 0.572 |
P, pathogenic; LP, likely pathogenic; non-P, non-pathogenic; MSI, microsatellite instability; MSI-H, microsatellite instability high; MSI-L, microsatellite instability low; MSS, macrosatellite stable; MMR, mismatch repair; dMMR, deficient mismatch repair; pMMR, proficient mismatch repair; NA, not available.